Next Generation News and Research

RSS

NovaSom introduces MediTrack OSA management platform

NovaSom, Inc., the leader in obstructive sleep apnea (OSA) home testing and cost-containment solutions, announces the launch of its next generation MediTrack cloud-based CRM application.

1 Dec 2011

Ambry Genetics deploys EMC Isilon scale-out NAS for gene sequencing

EMC Corporation today announced that Ambry Genetics, a leading commercial provider of clinical diagnostic and genomic services, has deployed EMC Isilon scale-out NAS to power its advanced gene sequencing operations, enabling Ambry to advance a range of scientific pursuits while easily managing 100 percent data growth annually.

30 Nov 2011

KI, Mayo Clinic to collaborate on education, research and innovation

Mayo Clinic and the Swedish medical university Karolinska Institutet will sign a long-term agreement to collaborate on education, research and innovation. The two institutions, recognized for leadership in medical research, training and patient care, will pursue joint investigations in regenerative medicine, individualized medicine, metabolism, neurosciences and aging research.

30 Nov 2011

Toshiba introduces Adaptive Iterative Dose Reduction 3D technology at RSNA 2011

To make today's CT examinations even safer, Toshiba America Medical Systems, Inc., unveils next generation dose reduction technology, Adaptive Iterative Dose Reduction 3D, at this year's Radiological Society of North America (RSNA) annual meeting in Chicago.

29 Nov 2011

NIH awards $3.2M for development of highly efficient system of generating nucleic acid molecules

The National Institutes of Health (NIH) has awarded $3.2 million to a team of preeminent engineering, chemistry, and biology researchers to develop a highly efficient system of generating nucleic acid molecules, called aptamers.

29 Nov 2011

URMC selects Acuo UCP3 as new vendor neutral archive solution

Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that University of Rochester Medical Center (URMC) has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.

28 Nov 2011

CHRISTUS Health selects Acuo UCP3 as new vendor neutral archive solution

Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.

28 Nov 2011

New creative uses of DNA 'barcoding'

The newfound scientific power to quickly "fingerprint" species via DNA is being deployed to unmask quack herbal medicines, reveal types of ancient Arctic life frozen in permafrost, expose what eats what in nature, and halt agricultural and forestry pests at borders, among other applications across a wide array of public interests.

28 Nov 2011

Mass immunization with cervical cancer vaccine switched to a more effective variety

Cervarix is currently offered to girls aged 12 and 13 years to protect against strains of the sexually transmitted human papillomavirus (HPV), which causes most cases of cancer of the cervix, the neck of the womb. Cervarix was picked by the Labour government for the first four-year phase of the NHS programme in 2008 because it offered ‘best overall value’ and more than five million doses have been given.

27 Nov 2011

Ziehm Imaging to highlight Vision RFD hybrid at RSNA 2011

Ziehm Imaging, leading developer, manufacturer and supplier of mobile C-arms, presents its innovative, award-winning product portfolio at RSNA 2011. Latest market analyst reports (GIA[1]) predict substantial growth for the fluoroscopy and mobile C-arm market segments that will be substantially driven by the growing number of minimally invasive procedures.

25 Nov 2011

Cameras in the form of a pill

Cameras ingested in the form of a pill make it possible to examine areas of the stomach and intestines that cannot be reached using traditional equipment. Norwegian researchers are busy developing the next-generation camera pill.

25 Nov 2011

BD MAX MRSA Assay receives CE Mark approval

BD Diagnostics, a segment of BD, today announced that it obtained CE Marking for the BD MAX MRSA Assay to rapidly and accurately identify methicillin-resistant Staphylococcus aureus (MRSA) in patients.

From BD (Becton, Dickinson and Company) 24 Nov 2011

Scientists identify MEGF10 defective gene responsible for muscle weakness

An international team of researchers from England and the Charité - Universitätsmedizin Berlin has presented new findings regarding the function of muscle stem cells, which are published in the current issue of the journal Nature Genetics.

23 Nov 2011

Advaxis completes ADXS-HER2 pre-IND meeting with FDA

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, completed a pre-IND meeting with the FDA on November 22, 2011 to discuss the development plan for ADXS-HER2, an immunotherapy for the treatment of HER2 expressing cancers.

23 Nov 2011

TJU expands Jefferson Medical College

Thomas Jefferson University announces the expansion of Jefferson Medical College with the creation of its Delaware Branch Campus. The Campus includes three participating hospitals - Christiana Care Health System, Nemours/Alfred I. duPont Hospital for Children and the Wilmington Veterans Affairs Hospital.

23 Nov 2011

GPS at WUSTL now offers new cancer genetic test

Physicians can now take advantage of a new genetics test -- one of the first of its kind to be offered in the United States -- that can help determine the best treatment for cancer patients.

23 Nov 2011

Study evaluates safety and effectiveness of Diamondback device for heart attacks

Drilling through concrete to create an opening may sound more like construction than medicine, but the approach is similar to what researchers at Orlando Regional Medical Center (ORMC) are doing in a clinical trial to evaluate a device that breaks through hardened coronary arteries, in an effort to prevent heart attacks and relieve chest pain.

23 Nov 2011

FDA approves Medtronic's iPro2 Professional continuous glucose monitoring system

Medtronic, Inc. today announced the Food and Drug Administration (FDA) approval of iPro2, a next generation Professional continuous glucose monitoring (CGM) system and the latest in a series of recent diabetes technology approvals and innovations from the company.

From Medtronic 22 Nov 2011

MIT, Pfizer announce new location for CVMED and Neuroscience research units

Pfizer Inc. and the Massachusetts Institute of Technology (MIT) today held the official groundbreaking of the new location of Pfizer's Cardiovascular, Metabolic and Endocrine Diseases (CVMED) and Neuroscience research units at 610 Main Street, Cambridge, MA.

22 Nov 2011

WaferGen third quarter revenue decreases to $89,000

WaferGen Biosystems, Inc., an emerging genomic analysis company, today reported financial results for the three and nine months ended September 30, 2011 and announced a revised plan to commercialize and increase adoption of its SmartChip System.

21 Nov 2011